The Clinical Features of Inflammatory Bowel Disease in Patients with Obesity

Figure 3

Cumulative probabilities of medication use and bowel resection in Crohn’s disease patients with obesity and matched controls (subgroup analysis): (a) corticosteroids, (b) thiopurines, (c) anti-TNF agents, and (d) bowel resection.

(a)

(b)

(c)

(d)